RATIONALE: 22q11 deletion syndrome (22q11DS) is associated with an increased risk for psychotic disorders, suggesting a relationship between genotypes and the pathophysiology of psychotic disorders. Two genes in the deleted region, catechol-O-methyl-transferase (COMT) and proline dehydrogenase (oxidase) 1 (PRODH), contain polymorphisms associated with neuropsychiatric phenotypes. OBJECTIVES: Here, we explored the association between polymorphisms and full-scale intelligence (FSIQ), startle reactivity (SR) and prepulse inhibition (PPI) in adults with 22q11DS. METHODS: Forty-five adults with 22q11DS were genotyped for PRODH rs450046, rs372055 and COMT Val(158)Met. Plasma proline levels, FSIQ, SR and PPI were measured. RESULTS: Thirty-five percent of the subjects were hyperprolinemic with a median proline value of 456 μmol/L. C allele carriers of PRODH rs450046 had a lower FSIQ compared to T allele carriers, indicating the C allele to be a risk allele (C allele: mean FSIQ 60.2 (sd 8.7); T allele: mean FSIQ 73.7 (sd 11.5); F 1,43 = 7.59; p = 0.009; partial η (2) = 0.15). A significant interaction effect of proline levels and COMT Val(158)Met genotype was found for SR (F 1,16 = 7.9; p = 0.01; partial η (2) = 0.33), but not for PPI and FSIQ. In subjects with hyperprolinemia, the COMT Val(158)Met genotype effect on SR was stronger than in subjects with normal proline levels. CONCLUSIONS: Overall, these data provide further evidence for the risk effect of elevated proline levels combined with the COMT Met allele and support the possibilities of using 22q11DS as a model to investigate genotype effects on psychiatric disorders.
RATIONALE: 22q11 deletion syndrome (22q11DS) is associated with an increased risk for psychotic disorders, suggesting a relationship between genotypes and the pathophysiology of psychotic disorders. Two genes in the deleted region, catechol-O-methyl-transferase (COMT) and proline dehydrogenase (oxidase) 1 (PRODH), contain polymorphisms associated with neuropsychiatric phenotypes. OBJECTIVES: Here, we explored the association between polymorphisms and full-scale intelligence (FSIQ), startle reactivity (SR) and prepulse inhibition (PPI) in adults with 22q11DS. METHODS: Forty-five adults with 22q11DS were genotyped for PRODHrs450046, rs372055 and COMTVal(158)Met. Plasma proline levels, FSIQ, SR and PPI were measured. RESULTS: Thirty-five percent of the subjects were hyperprolinemic with a median proline value of 456 μmol/L. C allele carriers of PRODHrs450046 had a lower FSIQ compared to T allele carriers, indicating the C allele to be a risk allele (C allele: mean FSIQ 60.2 (sd 8.7); T allele: mean FSIQ 73.7 (sd 11.5); F 1,43 = 7.59; p = 0.009; partial η (2) = 0.15). A significant interaction effect of proline levels and COMTVal(158)Met genotype was found for SR (F 1,16 = 7.9; p = 0.01; partial η (2) = 0.33), but not for PPI and FSIQ. In subjects with hyperprolinemia, the COMTVal(158)Met genotype effect on SR was stronger than in subjects with normal proline levels. CONCLUSIONS: Overall, these data provide further evidence for the risk effect of elevated proline levels combined with the COMT Met allele and support the possibilities of using 22q11DS as a model to investigate genotype effects on psychiatric disorders.
Authors: Nicole C Allen; Sachin Bagade; Matthew B McQueen; John P A Ioannidis; Fotini K Kavvoura; Muin J Khoury; Rudolph E Tanzi; Lars Bertram Journal: Nat Genet Date: 2008-07 Impact factor: 38.330
Authors: H Jacquet; C Demily; E Houy; B Hecketsweiler; J Bou; G Raux; J Lerond; G Allio; S Haouzir; A Tillaux; C Bellegou; G Fouldrin; P Delamillieure; J F Ménard; S Dollfus; T D'Amato; M Petit; F Thibaut; T Frébourg; D Campion Journal: Mol Psychiatry Date: 2005-05 Impact factor: 15.992
Authors: Hui Liu; Simon C Heath; Christina Sobin; J Louw Roos; Brandi L Galke; Maude L Blundell; Marge Lenane; Brian Robertson; Ellen M Wijsman; Judith L Rapoport; Joseph A Gogos; Maria Karayiorgou Journal: Proc Natl Acad Sci U S A Date: 2002-03-12 Impact factor: 11.205
Authors: Beate Glaser; Valentina Moskvina; George Kirov; Kieran C Murphy; Hywel Williams; Nigel Williams; Michael J Owen; Michael C O'Donovan Journal: Schizophr Res Date: 2006-07-21 Impact factor: 4.939
Authors: P Anne Weisner; Chih-Ying Chen; Younguk Sun; Jennifer Yoo; Wei-Chun Kao; Huimin Zhang; Emily T Baltz; Joseph M Troy; Lisa Stubbs Journal: G3 (Bethesda) Date: 2019-11-05 Impact factor: 3.154
Authors: Esther D A van Duin; Jenny Ceccarini; Jan Booij; Zuzana Kasanova; Claudia Vingerhoets; Jytte van Huijstee; Alexander Heinzel; Siamak Mohammadkhani-Shali; Oliver Winz; Felix Mottaghy; Inez Myin-Germeys; Thérèse van Amelsvoort Journal: Psychol Med Date: 2019-04-02 Impact factor: 7.723
Authors: Bruna S da Silva; Douglas T Leffa; Walter O Beys-da-Silva; Iraci L S Torres; Diego L Rovaris; Marcelo M Victor; Luis A Rohde; Nina R Mota; Carla de Oliveira; Markus Berger; John R Yates; Renuka Sabnis; Ramón Díaz Peña; Alexandre Rosa Campos; Eugenio H Grevet; Lucelia Santi; Claiton H D Bau; Verônica Contini Journal: Transl Psychiatry Date: 2019-11-18 Impact factor: 6.222